Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$11.76 -0.11 (-0.93%)
At close: Sep 29, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Total Liabilities (2015 - 2026)

Updated

Corvus Pharmaceuticals' Total Liabilities came in at $13.95 million for Q2 2026, up 51.0% from $9.23 million a year earlier and up 11.4% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Total Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Corvus Pharmaceuticals' Total Liabilities was $9.91 million, down 72.7% from FY2024.

  • Total Liabilities carries a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
  • Going back by year, Total Liabilities was $36.34 million in FY2024 (+429.0%), $6.87 million in FY2023 (-43.3%), $12.13 million in FY2022 (-1.4%) and $12.29 million in FY2021 (-8.1%).
  • The Q2 2026 figure represents the highest quarterly Total Liabilities since Q4 2024.
  • Year-over-year, Total Liabilities increased in five of the last eight quarters, with growth averaging 109.5%.
  • The fastest year-over-year change in Total Liabilities over five years came in Q3 2024 (growth of 506.4%), and the weakest in Q3 2025 (a decline of 81.2%).
  • Business Quant data shows CRVS's Total Liabilities at $12.52 million (Q1 2026), $9.91 million (Q4 2025) and $8.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Corvus Pharmaceuticals 998.52 Mn 486.96 Mn - 13.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.95 Mn
Mar 31, 2026 12.52 Mn
Dec 31, 2025 9.91 Mn
Sep 30, 2025 8.71 Mn
Jun 30, 2025 9.23 Mn
Mar 31, 2025 10.11 Mn
Dec 31, 2024 36.34 Mn
Sep 30, 2024 46.41 Mn
Jun 30, 2024 13.34 Mn
Mar 31, 2024 6.72 Mn
Dec 31, 2023 6.87 Mn
Sep 30, 2023 7.65 Mn
Jun 30, 2023 8.56 Mn
Mar 31, 2023 9.33 Mn
Dec 31, 2022 12.13 Mn
Sep 30, 2022 15.67 Mn
Jun 30, 2022 12.16 Mn
Mar 31, 2022 11.57 Mn
Dec 31, 2021 12.29 Mn
Sep 30, 2021 14.18 Mn
API Access

Corvus Pharmaceuticals Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=CRVS&period=max&api_key=YOUR_API_KEY